Literature DB >> 648555

The current causes of death in patients with malignant melanoma.

D R Budman, E Camacho, R E Wittes.   

Abstract

Entities:  

Mesh：

Year:  1978        PMID： 648555     DOI： 10.1016/0014-2964(78)90201-3

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0014-2964            Impact factor:   9.162


× No keyword cloud information.
  28 in total

Review 1.  Clinical Management of Multiple Melanoma Brain Metastases: A Systematic Review.

Authors:  Sharad Goyal; Ann W Silk; Sibo Tian; Janice Mehnert; Shabbar Danish; Sinthu Ranjan; Howard L Kaufman
Journal:  JAMA Oncol       Date:  2015-08       Impact factor: 31.777

2.  It is never too late: ultra-late recurrence of melanoma with distant metastases.

Authors:  Dina Mansour; Deepak Kejariwal
Journal:  BMJ Case Rep       Date:  2012-03-08

Review 3.  Melanoma brain metastases: an unmet challenge in the era of active therapy.

Authors:  Vikram Gorantla; John M Kirkwood; Hussein A Tawbi
Journal:  Curr Oncol Rep       Date:  2013-10       Impact factor: 5.075

Review 4.  [Malignant melanoma. Diagnosis and therapy].

Authors:  E S Schultz; G Schuler
Journal:  HNO       Date:  2005-11       Impact factor: 1.284

Review 5.  Systemic therapy of brain metastases: non-small cell lung cancer, breast cancer, and melanoma.

Authors:  Marc C Chamberlain; Christina S Baik; Vijayakrishna K Gadi; Shailender Bhatia; Laura Q M Chow
Journal:  Neuro Oncol       Date:  2017-01       Impact factor: 12.300

6.  Safety and immunogenicity of vaccination with MART-1 (26-35, 27L), gp100 (209-217, 210M), and tyrosinase (368-376, 370D) in adjuvant with PF-3512676 and GM-CSF in metastatic melanoma.

Authors:  Ahmad A Tarhini; Siyang Leng; Stergios J Moschos; Yan Yin; Cindy Sander; Yan Lin; William E Gooding; John M Kirkwood
Journal:  J Immunother       Date:  2012-05       Impact factor: 4.456

7.  Chemotherapy response assessment in stage IV melanoma patients-comparison of 18F-FDG-PET/CT, CT, brain MRI, and tumormarker S-100B.

Authors:  Klaus Strobel; Reinhard Dummer; Hans C Steinert; Katrin Baumann Conzett; Karin Schad; Marisol Pérez Lago; Jan D Soyka; P Veit-Haibach; Burkhardt Seifert; V Kalff
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-05-06       Impact factor: 9.236

8.  Cranial irradiation after surgical excision of brain metastases in melanoma patients.

Authors:  J M Skibber; S J Soong; L Austin; C M Balch; R E Sawaya
Journal:  Ann Surg Oncol       Date:  1996-03       Impact factor: 5.344

9.  Immune checkpoint inhibitor therapy may increase the incidence of treatment-related necrosis after stereotactic radiosurgery for brain metastases: a systematic review and meta-analysis.

Authors:  Jeffrey P Guenette; Raymond Y Huang; Pyeong Hwa Kim; Chong Hyun Suh; Ho Sung Kim; Kyung Won Kim; Dong Yeong Kim; Ayal A Aizer; Rifaquat Rahman
Journal:  Eur Radiol       Date:  2020-11-25       Impact factor: 5.315

10.  Efficacy and toxicity of whole brain radiotherapy in patients with multiple cerebral metastases from malignant melanoma.

Authors:  Henrik Hauswald; Jan-Oliver Dittmar; Daniel Habermehl; Stefan Rieken; Florian Sterzing; Jürgen Debus; Stephanie E Combs
Journal:  Radiat Oncol       Date:  2012-08-02       Impact factor: 3.481
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.